Alivus Life Sciences inks pact with Torrent Urja 19

03 Apr 2025 Evaluate

Alivus Life Sciences has entered into Share Purchase cum Subscription Shareholders’ Agreement and Power Supply Agreement with Torrent Urja 19 for consumption and supply of renewable energy (RE). The company will acquire minimum 9.21% stake in Torrent Urja 19.

In addition, the company’s promoter company -- Nirma has also entered into a similar Power Supply Agreement and Share Purchase cum Subscription Shareholders Agreement with Torrent Urja 19 whereby Nirma will acquire minimum 16.99% stake in Torrent Urja 19. 

Alivus Life Sciences (Formally known as Glenmark Life Sciences) is a leading developer and manufacturer of select high value, non-commoditized active pharmaceutical ingredients (APIs) in chronic therapeutic areas, including cardiovascular disease (CVS), central nervous system disease (CNS), pain management and diabetes. 


Alivus Life Sciences Share Price

977.75 -27.85 (-2.77%)
09-Apr-2025 10:14 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.60
Dr. Reddys Lab 1094.50
Cipla 1410.70
Lupin 1920.00
Zydus Lifesciences 841.15
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...